From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
Genome Medicine
Perera-Bel, Júlia J; Hutter, Barbara B; Heining, Christoph C; Bleckmann, Annalen A; Fröhlich, Martina M; Fröhling, Stefan S; Glimm, Hanno H; Brors, Benedikt B; Beißbarth, Tim T
BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib.
Pigment Cell & Melanoma Research
Ranzani, Marco M; Alifrangis, Constantine C; Perna, Daniele D; Dutton-Regester, Ken K; Pritchard, Antonia A; Wong, Kim K; Rashid, Mamunur M; Robles-Espinoza, Carla Daniela CD; Hayward, Nicholas K NK; McDermott, Ultan U; Garnett, Mathew M; Adams, David J DJ